The Class I recall is the second one for Abbott’s HeartMate 3 device this year and follows 70 injuries and two patient deaths ...
which is used to monitor patients who have an implantable HeartMate 3 device. The recall was issued after the FDA identified issues with the seal interface between the LVAD inflow cannula and the ...
Abbott’s research has shown that its HeartMate 3 pump can extend the lives of advanced heart patients by at least five years.
In the latest notice, which follows a February recall of the device for a separate issue, Abbott took action due to reports of blood leakage and air entrapment.
FDA tells healthcare facilities to avoid using two Getinge heart devices due to safety concerns. Company halts promotion & sales until quality issues are fixed.
Initiated by Abbott/Thoratec and deemed Class I by the FDA, the recall is in response to reports of 70 injuries and two ...
(Circulation)Recommendations for postpartum care were released by the American Heart Association, and include monitoring for ...
Once again, the top players in cardiac care gathered en masse as Heart Rhythm Society (HRS) 2024 took place in Boston last ...
Last week, the FDA advised providers against using Getinge’s Cardiosave intra-aortic balloon pumps and Cardiohelp cardiopulmonary bypass systems after seeing the company start 20 recalls of the ...
Cutting-edge tool analyzes data from cardiac remote monitoring devices to assess whether a patient is at high risk of experiencing worsening heart failure, enabling medical teams to intervene and ...